Case study 29 warfarin therapy
Found 8 free book(s)
Case study 29: Warfarin therapy
www.impactteam.info3 Case study 29: Warfarin therapy Scenario Bob, a 65-year-old man with atrial fibrillation, has been using warfarin for the past 12 months after he presented to the local emergency departme nt …
Section5 - nes.scot.nhs.uk
www.nes.scot.nhs.ukSection5 29 Factorsaffectingwarfarin Objectives On completion of this section you should be able to: analyse the wide range of factors that can affect warfarin therapy summarise the main factors that pharmacists and pharmacy technicians should be particularly aware of (eg, drug interactions,
DRUG NAME: Bicalutamide - BC Cancer
www.bccancer.bc.caBicalutamide . Fatigue: Bicalutamide monotherapy causes a slightly higher incidence of fatigue than surgical castration. 2. Gynecomastia and breast tenderness: Gynecomastia is more common with bicalutamide 150 mg monotherapy (38%) than combination therapy with LHRHa (6%).
Prothrombinex -VF NAME OF THE MEDICINE DESCRIPTION
www.medsafe.govt.nzProthrombinex-VF NZ DS 19.00 Page 4 of 17 reversal. Patients were grouped either with the intention to achieve complete reversal to INR <1.4 or partial reversal to INR 1.4–2.0, based on the reason for reversal of anticoagulation.
Electrical Cardioversion - Atrial fibrillation
afibbers.orgElectrical Cardioversion By Hans R. Larsen MSc ChE Background Cardioversion is used to convert a patient experiencing highly symptomatic or persistent atrial
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET . New Zealand Data Sheet Page . 2. of . 17. The dose should be adjusted to the needs of the individual patient to achieve adequate
DIRECTIONS FOR USE - USA Restylane Refyne
www.galdermausa.comPage 1 of 12 DIRECTIONS FOR USE - USA Restylane® Refyne Caution: Federal (USA) law restricts this device to sale by or on the order of a licensed physician or properly licensed practitioner. BEFORE USING PRODUCT, READ THE FOLLOWING
BLUNT CEREBROVASCULAR INJURIES - SurgicalCriticalCare.net
surgicalcriticalcare.net3 Approved 6/5/2006 Revised 5/01/2012, 8/29/2015 neurological findings were present in 42% of patients. Of the survivors, 45% of patients had significant impairment.